tiprankstipranks
Trending News
More News >
Knight Therapeutics (TSE:GUD)
TSX:GUD
Canadian Market
Advertisement

Knight Therapeutics (GUD) Technical Analysis

Compare
99 Followers

Summary of all the Indicators

Overall Consensus
Strong Buy
15Bullish
6Neutral
1Bearish
Technical Analysis Consensus
Buy
3Bullish
6Neutral
1Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Knight Therapeutics’s (GUD) Moving Averages Convergence Divergence (MACD) indicator is 0.05, suggesting Knight Therapeutics is a Sell.
Knight Therapeutics’s (GUD) 20-Day exponential moving average is 6.04, while Knight Therapeutics’s (GUD) share price is C$6.12, making it a Buy.
Knight Therapeutics’s (GUD) 50-Day exponential moving average is 5.97, while Knight Therapeutics’s (GUD) share price is C$6.12, making it a Buy.

Knight Therapeutics (GUD) Pivot Points

Jul 25, 2025, 03:42 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.89
5.94
6.03
6.08
6.17
6.22
6.31
Fibonacci
5.94
6.00
6.03
6.08
6.14
6.17
6.22
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Knight Therapeutics (GUD) Moving Averages

Jul 25, 2025, 03:42 AM
Period
Simple
Exponential
MA5
6.10Buy
6.09Buy
MA10
6.10Buy
6.08Buy
MA20
6.02Buy
6.04Buy
MA50
5.93Buy
5.97Buy
MA100
5.91Buy
5.89Buy
MA200
5.69Buy
5.77Buy
Knight Therapeutics’s (GUD) 10-Day exponential moving average is 6.08, while Knight Therapeutics’s (GUD) share price is C$6.12, making it a Buy.
Knight Therapeutics’s (GUD) 100-Day exponential moving average is 5.89, while Knight Therapeutics’s (GUD) share price is C$6.12, making it a Buy.
Knight Therapeutics’s (GUD) stock price is C$6.12 and Knight Therapeutics’s (GUD) 50-day simple moving average is 5.93, creating a Buy signal.
Knight Therapeutics’s (GUD) stock price is C$6.12 and Knight Therapeutics’s (GUD) 100-day simple moving average is 5.91, creating a Buy signal.
Knight Therapeutics’s (GUD) stock price is C$6.12 and Knight Therapeutics’s (GUD) 200-day simple moving average is 5.69, creating a Buy signal.

Knight Therapeutics (GUD) Technical Indicators

Jul 25, 2025, 03:42 AM
Name
Value
Implied Action
RSI (14)
57.12
Neutral
STOCH (9,6)
30.67
Neutral
STOCHRSI (14)
47.06
Neutral
MACD (12,26)
0.05
Sell
ADX (14)
29.10
Neutral
Williams %R
-52.00
Buy
CCI (14)
71.66
Neutral
ATR (14)
0.11
-
Ultimate Oscillator
41.30
Neutral
ROC
1.66
Buy
Knight Therapeutics’s (GUD) Relative Strength Index (RSI) is 57.12, creating a Neutral signal.
Knight Therapeutics’s (GUD) Trend Strength Indicator (ADX) is 29.10, creating a Neutral signal.
Knight Therapeutics’s (GUD) Commodity Channel Index (CCI) is 71.66, creating a Neutral signal.
Knight Therapeutics’s (GUD) Price Rate of Change (ROC) is 1.66, creating a Buy signal.

FAQ

Is GUD a Buy, Hold, or Sell?
Based on GUD’s technical indicators, GUD is a Strong Buy.
    What is GUD’s RSI (14)?
    GUD’s RSI (14) is 57.12, which suggests GUD is a Neutral.
      What is GUD’s MACD?
      GUD’s MACD is 0.05, which suggests GUD is a Sell.
        What is GUD’s 5-day moving average?
        GUD’s 5-day moving average is 6.10, which suggests GUD is a Buy.
          What is GUD’s 20-day moving average?
          GUD 20-day moving average is 6.02, which suggests GUD is a Buy.
            What is GUD’s 50-day moving average?
            GUD’s 50-day moving average is 5.93, which suggests GUD is a Buy.
              What is GUD’s 200-day moving average?
              GUD’s 200-day moving average is 5.69, which suggests GUD is a Buy.
                What is GUD’s Williams % R (14)?
                GUD’s Williams % R (14) is -52.00, which suggests GUD is a Buy.
                  What is GUD’s CCI (14)?
                  GUD’s CCI (14) is 71.66, which suggests GUD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis